Your session is about to expire
← Back to Search
Nerve Block for Spinal Cord Injury-Related Shoulder Pain
Study Summary
This trial will test if a suprascapular nerve block can help people with chronic shoulder pain and spinal cord injury.
- Chronic Shoulder Pain
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Frozen shoulderYou have received regenerative medicine treatment in the past.You use a wheelchair that you have to move with your hands.You are between 18 and 70 years old, regardless of your gender.You have had cancer that was actively growing within the past 5 years.You had a steroid injection in the last four weeks.You have had a spinal cord injury at least twelve months ago, and the injury is located between the C6 and L5 vertebrae.You have had shoulder pain for at least 6 months that hasn't improved with treatments like physical therapy or medication, and the pain is rated as 4 or more out of 10 on a pain scale.You cannot walk, unless it's for exercise or therapy.
- Group 1: Suprascapular Nerve Block in Participants with Spinal Cord Injuries (SCI) Group
- Approved for 10 Other Conditions - This treatment demonstrated efficacy for 10 other conditions.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are individuals aged 30 or more eligible to participate in this research?
"The age range that this trial is willing to accept patients is between 18 to 70 years old."
Has the FDA cleared Suprascapular Nerve Block for public use?
"Suprascapular Nerve Block is a Phase 4 trial, meaning that it is an approved treatment, and thus it received a score of 3."
What benefits does this clinical trial hope to bring patients?
"The primary metric for success in this clinical trial is the number of patients that experience adverse events related to the treatment, which will be measured a month after the procedure. Additionally, the study will look at secondary objectives like changes in DASH Questionnaire scores (a measure of ability to perform upper extremity activities), number of participants at each Global Satisfaction Rating, and changes in NRS scores (a measure of pain levels)."
Are there still vacancies in this research project for test subjects?
"According to the latest update on clinicaltrials.gov, this particular study is not looking for new patients at this time. The trial was initially posted on 1/1/2023, with the most recent edit on 7/30/2022. There are 448 other trials that are open for recruitment."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger